Literature DB >> 13103835

Hamman-Rich syndrome; analysis of current concepts and report of three precipitous deaths following cortisone and corticotropin (ACTH) withdrawal.

J W PEABODY, H A BUECHNER, A E ANDERSON.   

Abstract

Entities:  

Keywords:  ACTH/therapeutic use; CORTISONE/therapeutic use; LUNGS/diseases

Mesh：

Substances：

Year:  1953        PMID： 13103835     DOI： 10.1001/archinte.1953.00240240042003

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN： 0888-2479


× No keyword cloud information.
  9 in total

1.  Therapy of the idiopathic fibrosis of the lung.

Authors:  U H Cegla; R F Kroidl; J Meier-Sydow; C Thiel; G Czarnecki; F Schreiber
Journal:  Pneumonologie       Date:  1975-09-26

2.  Treatment of the Hamman-Rich syndrome with cortisone.

Authors:  J READ; R A HOLLAND
Journal:  Thorax       Date:  1959-03       Impact factor: 9.139

3.  Chronic diffuse interstitial fibrosis of the lungs.

Authors:  J G SCADDING
Journal:  Br Med J       Date:  1960-02-13

4.  Honeycomb lung and chronic rheumatoid arthritis; a case report.

Authors:  A S DIXON; J BALL
Journal:  Ann Rheum Dis       Date:  1957-06       Impact factor: 19.103

5.  Observations on the Hamman-Rich syndrome.

Authors:  P F Wagley
Journal:  Trans Am Clin Climatol Assoc       Date:  1973

6.  Pulmonary fibrosis and hepatitis.

Authors:  P Lynne-Davies; B J Sproule
Journal:  Can Med Assoc J       Date:  1967-04-15       Impact factor: 8.262

Review 7.  Idiopathic pulmonary fibrosis: a historical review.

Authors:  J Homolka
Journal:  CMAJ       Date:  1987-12-01       Impact factor: 8.262

8.  Tridimensional photographic reconstruction in a study of the pathogenesis of honeycomb lung.

Authors:  J C Pimentel
Journal:  Thorax       Date:  1967-09       Impact factor: 9.139

9.  Generalized cytomegalic inclusion-body disease associated with pneumocystis pneumonia in adults. A report of three cases. with Wegener's granulomatosis. thrombotic purpura, and Hodgkin's disease as predisposing conditions.

Authors:  W S SYMMERS
Journal:  J Clin Pathol       Date:  1960-01       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.